COVID-19 Impact on Global Disease Risk and Health DNA Test Market Insights, Forecast to 2026

1 Study Coverage

• 1.1 Disease Risk and Health DNA Test Product Introduction
• 1.2 Market Segments
• 1.3 Key Disease Risk and Health DNA Test Manufacturers Covered: Ranking by Revenue
• 1.4 Market by Type
  • 1.4.1 Global Disease Risk and Health DNA Test Market Size Growth Rate by Type
  • 1.4.2 Celiac Disease
  • 1.4.3 Parkinson Disease
  • 1.4.4 Alzheimer Disease
  • 1.4.5 Other
• 1.5 Market by Application
  • 1.5.1 Global Disease Risk and Health DNA Test Market Size Growth Rate by Application
  • 1.5.2 Online
  • 1.5.3 Offline
• 1.6 Coronavirus Disease 2019 (Covid-19): Disease Risk and Health DNA Test Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Disease Risk and Health DNA Test Industry
    • 1.6.1.1 Disease Risk and Health DNA Test Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Disease Risk and Health DNA Test Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Disease Risk and Health DNA Test Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Executive Summary

• 2.1 Global Disease Risk and Health DNA Test Market Size Estimates and Forecasts
  • 2.1.1 Global Disease Risk and Health DNA Test Revenue 2015-2026
  • 2.1.2 Global Disease Risk and Health DNA Test Sales 2015-2026
• 2.2 Disease Risk and Health DNA Test Market Size by Region: 2020 Versus 2026
  • 2.2.1 Global Disease Risk and Health DNA Test Retrospective Market Scenario in Sales by Region: 2015-2020
  • 2.2.2 Global Disease Risk and Health DNA Test Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Disease Risk and Health DNA Test Competitor Landscape by Players

• 3.1 Disease Risk and Health DNA Test Sales by Manufacturers
  • 3.1.1 Disease Risk and Health DNA Test Sales by Manufacturers (2015-2020)
  • 3.1.2 Disease Risk and Health DNA Test Sales Market Share by Manufacturers (2015-2020)
• 3.2 Disease Risk and Health DNA Test Revenue by Manufacturers
  • 3.2.1 Disease Risk and Health DNA Test Revenue by Manufacturers (2015-2020)
  • 3.2.2 Disease Risk and Health DNA Test Revenue Share by Manufacturers (2015-2020)
  • 3.2.3 Global Disease Risk and Health DNA Test Market Concentration Ratio (CR5 and HHI) (2015-2020)
  • 3.2.4 Global Top 10 and Top 5 Companies by Disease Risk and Health DNA Test Revenue in 2019
  • 3.2.5 Global Disease Risk and Health DNA Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Disease Risk and Health DNA Test Price by Manufacturers
• 3.4 Disease Risk and Health DNA Test Manufacturing Base Distribution, Product Types
  • 3.4.1 Disease Risk and Health DNA Test Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Disease Risk and Health DNA Test Product Type
  • 3.4.3 Date of International Manufacturers Enter into Disease Risk and Health DNA Test Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Disease Risk and Health DNA Test Market Size by Type (2015-2020)
  • 4.1.1 Global Disease Risk and Health DNA Test Sales by Type (2015-2020)
  • 4.1.2 Global Disease Risk and Health DNA Test Revenue by Type (2015-2020)
  • 4.1.3 Disease Risk and Health DNA Test Average Selling Price (ASP) by Type (2015-2026)
• 4.2 Global Disease Risk and Health DNA Test Market Size Forecast by Type (2021-2026)
  • 4.2.1 Global Disease Risk and Health DNA Test Sales Forecast by Type (2021-2026)
  • 4.2.2 Global Disease Risk and Health DNA Test Revenue Forecast by Type (2021-2026)
  • 4.2.3 Disease Risk and Health DNA Test Average Selling Price (ASP) Forecast by Type (2021-2026)
• 4.3 Global Disease Risk and Health DNA Test Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

• 5.1 Global Disease Risk and Health DNA Test Market Size by Application (2015-2020)
  • 5.1.1 Global Disease Risk and Health DNA Test Sales by Application (2015-2020)
  • 5.1.2 Global Disease Risk and Health DNA Test Revenue by Application (2015-2020)
  • 5.1.3 Disease Risk and Health DNA Test Price by Application (2015-2020)
• 5.2 Disease Risk and Health DNA Test Market Size Forecast by Application (2021-2026)
  • 5.2.1 Global Disease Risk and Health DNA Test Sales Forecast by Application (2021-2026)
  • 5.2.2 Global Disease Risk and Health DNA Test Revenue Forecast by Application (2021-2026)
  • 5.2.3 Global Disease Risk and Health DNA Test Price Forecast by Application (2021-2026)

6 North America

• 6.1 North America Disease Risk and Health DNA Test by Country
  • 6.1.1 North America Disease Risk and Health DNA Test Sales by Country
  • 6.1.2 North America Disease Risk and Health DNA Test Revenue by Country
  • 6.1.3 U.S.
  • 6.1.4 Canada
• 6.2 North America Disease Risk and Health DNA Test Market Facts & Figures by Type
• 6.3 North America Disease Risk and Health DNA Test Market Facts & Figures by Application

7 Europe

• 7.1 Europe Disease Risk and Health DNA Test by Country
  • 7.1.1 Europe Disease Risk and Health DNA Test Sales by Country
  • 7.1.2 Europe Disease Risk and Health DNA Test Revenue by Country
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 U.K.
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Disease Risk and Health DNA Test Market Facts & Figures by Type
• 7.3 Europe Disease Risk and Health DNA Test Market Facts & Figures by Application

8 Asia Pacific

• 8.1 Asia Pacific Disease Risk and Health DNA Test by Region
  • 8.1.1 Asia Pacific Disease Risk and Health DNA Test Sales by Region
  • 8.1.2 Asia Pacific Disease Risk and Health DNA Test Revenue by Region
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 South Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Taiwan
  • 8.1.9 Indonesia
  • 8.1.10 Thailand
  • 8.1.11 Malaysia
  • 8.1.12 Philippines
  • 8.1.13 Vietnam
• 8.2 Asia Pacific Disease Risk and Health DNA Test Market Facts & Figures by Type
• 8.3 Asia Pacific Disease Risk and Health DNA Test Market Facts & Figures by Application

9 Latin America

• 9.1 Latin America Disease Risk and Health DNA Test by Country
  • 9.1.1 Latin America Disease Risk and Health DNA Test Sales by Country
  • 9.1.2 Latin America Disease Risk and Health DNA Test Revenue by Country
  • 9.1.3 Mexico
  • 9.1.4 Brazil
  • 9.1.5 Argentina
• 9.2 Central & South America Disease Risk and Health DNA Test Market Facts & Figures by Type
• 9.3 Central & South America Disease Risk and Health DNA Test Market Facts & Figures by Application

10 Middle East and Africa

• 10.1 Middle East and Africa Disease Risk and Health DNA Test by Country
  • 10.1.1 Middle East and Africa Disease Risk and Health DNA Test Sales by Country
  • 10.1.2 Middle East and Africa Disease Risk and Health DNA Test Revenue by Country
  • 10.1.3 Turkey
  • 10.1.4 Saudi Arabia
  • 10.1.5 U.A.E
• 10.2 Middle East and Africa Disease Risk and Health DNA Test Market Facts & Figures by Type
• 10.3 Middle East and Africa Disease Risk and Health DNA Test Market Facts & Figures by Application

11 Company Profiles

• 11.1 23andMe
  • 11.1.1 23andMe Corporation Information
  • 11.1.2 23andMe Description, Business Overview and Total Revenue
  • 11.1.3 23andMe Sales, Revenue and Gross Margin (2015-2020)
  • 11.1.4 23andMe Disease Risk and Health DNA Test Products Offered
  • 11.1.5 23andMe Recent Development
• 11.2 MyHeritage
  • 11.2.1 MyHeritage Corporation Information
  • 11.2.2 MyHeritage Description, Business Overview and Total Revenue
  • 11.2.3 MyHeritage Sales, Revenue and Gross Margin (2015-2020)
  • 11.2.4 MyHeritage Disease Risk and Health DNA Test Products Offered
  • 11.2.5 MyHeritage Recent Development
• 11.3 LabCorp
  • 11.3.1 LabCorp Corporation Information
  • 11.3.2 LabCorp Description, Business Overview and Total Revenue
  • 11.3.3 LabCorp Sales, Revenue and Gross Margin (2015-2020)
  • 11.3.4 LabCorp Disease Risk and Health DNA Test Products Offered
  • 11.3.5 LabCorp Recent Development
• 11.4 Myriad Genetics
  • 11.4.1 Myriad Genetics Corporation Information
  • 11.4.2 Myriad Genetics Description, Business Overview and Total Revenue
  • 11.4.3 Myriad Genetics Sales, Revenue and Gross Margin (2015-2020)
  • 11.4.4 Myriad Genetics Disease Risk and Health DNA Test Products Offered
  • 11.4.5 Myriad Genetics Recent Development
• 11.5 Ancestry.com
  • 11.5.1 Ancestry.com Corporation Information
  • 11.5.2 Ancestry.com Description, Business Overview and Total Revenue
  • 11.5.3 Ancestry.com Sales, Revenue and Gross Margin (2015-2020)
  • 11.5.4 Ancestry.com Disease Risk and Health DNA Test Products Offered
  • 11.5.5 Ancestry.com Recent Development
• 11.6 Quest Diagnostics
  • 11.6.1 Quest Diagnostics Corporation Information
  • 11.6.2 Quest Diagnostics Description, Business Overview and Total Revenue
  • 11.6.3 Quest Diagnostics Sales, Revenue and Gross Margin (2015-2020)
  • 11.6.4 Quest Diagnostics Disease Risk and Health DNA Test Products Offered
  • 11.6.5 Quest Diagnostics Recent Development
• 11.7 Gene By Gene
  • 11.7.1 Gene By Gene Corporation Information
  • 11.7.2 Gene By Gene Description, Business Overview and Total Revenue
  • 11.7.3 Gene By Gene Sales, Revenue and Gross Margin (2015-2020)
  • 11.7.4 Gene By Gene Disease Risk and Health DNA Test Products Offered
  • 11.7.5 Gene By Gene Recent Development
• 11.8 DNA Diagnostics Center
  • 11.8.1 DNA Diagnostics Center Corporation Information
  • 11.8.2 DNA Diagnostics Center Description, Business Overview and Total Revenue
  • 11.8.3 DNA Diagnostics Center Sales, Revenue and Gross Margin (2015-2020)
  • 11.8.4 DNA Diagnostics Center Disease Risk and Health DNA Test Products Offered
  • 11.8.5 DNA Diagnostics Center Recent Development
• 11.9 Invitae
  • 11.9.1 Invitae Corporation Information
  • 11.9.2 Invitae Description, Business Overview and Total Revenue
  • 11.9.3 Invitae Sales, Revenue and Gross Margin (2015-2020)
  • 11.9.4 Invitae Disease Risk and Health DNA Test Products Offered
  • 11.9.5 Invitae Recent Development
• 11.10 IntelliGenetics
  • 11.10.1 IntelliGenetics Corporation Information
  • 11.10.2 IntelliGenetics Description, Business Overview and Total Revenue
  • 11.10.3 IntelliGenetics Sales, Revenue and Gross Margin (2015-2020)
  • 11.10.4 IntelliGenetics Disease Risk and Health DNA Test Products Offered
  • 11.10.5 IntelliGenetics Recent Development
• 11.1 23andMe
  • 11.1.1 23andMe Corporation Information
  • 11.1.2 23andMe Description, Business Overview and Total Revenue
  • 11.1.3 23andMe Sales, Revenue and Gross Margin (2015-2020)
  • 11.1.4 23andMe Disease Risk and Health DNA Test Products Offered
  • 11.1.5 23andMe Recent Development
• 11.12 Living DNA
  • 11.12.1 Living DNA Corporation Information
  • 11.12.2 Living DNA Description, Business Overview and Total Revenue
  • 11.12.3 Living DNA Sales, Revenue and Gross Margin (2015-2020)
  • 11.12.4 Living DNA Products Offered
  • 11.12.5 Living DNA Recent Development
• 11.13 EasyDNA
  • 11.13.1 EasyDNA Corporation Information
  • 11.13.2 EasyDNA Description, Business Overview and Total Revenue
  • 11.13.3 EasyDNA Sales, Revenue and Gross Margin (2015-2020)
  • 11.13.4 EasyDNA Products Offered
  • 11.13.5 EasyDNA Recent Development
• 11.14 Pathway Genomics
  • 11.14.1 Pathway Genomics Corporation Information
  • 11.14.2 Pathway Genomics Description, Business Overview and Total Revenue
  • 11.14.3 Pathway Genomics Sales, Revenue and Gross Margin (2015-2020)
  • 11.14.4 Pathway Genomics Products Offered
  • 11.14.5 Pathway Genomics Recent Development
• 11.15 Centrillion Technology
  • 11.15.1 Centrillion Technology Corporation Information
  • 11.15.2 Centrillion Technology Description, Business Overview and Total Revenue
  • 11.15.3 Centrillion Technology Sales, Revenue and Gross Margin (2015-2020)
  • 11.15.4 Centrillion Technology Products Offered
  • 11.15.5 Centrillion Technology Recent Development
• 11.16 Xcode
  • 11.16.1 Xcode Corporation Information
  • 11.16.2 Xcode Description, Business Overview and Total Revenue
  • 11.16.3 Xcode Sales, Revenue and Gross Margin (2015-2020)
  • 11.16.4 Xcode Products Offered
  • 11.16.5 Xcode Recent Development
• 11.17 Color Genomics
  • 11.17.1 Color Genomics Corporation Information
  • 11.17.2 Color Genomics Description, Business Overview and Total Revenue
  • 11.17.3 Color Genomics Sales, Revenue and Gross Margin (2015-2020)
  • 11.17.4 Color Genomics Products Offered
  • 11.17.5 Color Genomics Recent Development
• 11.18 Anglia DNA Services
  • 11.18.1 Anglia DNA Services Corporation Information
  • 11.18.2 Anglia DNA Services Description, Business Overview and Total Revenue
  • 11.18.3 Anglia DNA Services Sales, Revenue and Gross Margin (2015-2020)
  • 11.18.4 Anglia DNA Services Products Offered
  • 11.18.5 Anglia DNA Services Recent Development
• 11.19 African Ancestry
  • 11.19.1 African Ancestry Corporation Information
  • 11.19.2 African Ancestry Description, Business Overview and Total Revenue
  • 11.19.3 African Ancestry Sales, Revenue and Gross Margin (2015-2020)
  • 11.19.4 African Ancestry Products Offered
  • 11.19.5 African Ancestry Recent Development
• 11.20 Canadian DNA Services
  • 11.20.1 Canadian DNA Services Corporation Information
  • 11.20.2 Canadian DNA Services Description, Business Overview and Total Revenue
  • 11.20.3 Canadian DNA Services Sales, Revenue and Gross Margin (2015-2020)
  • 11.20.4 Canadian DNA Services Products Offered
  • 11.20.5 Canadian DNA Services Recent Development
• 11.21 DNA Family Check
  • 11.21.1 DNA Family Check Corporation Information
  • 11.21.2 DNA Family Check Description, Business Overview and Total Revenue
  • 11.21.3 DNA Family Check Sales, Revenue and Gross Margin (2015-2020)
  • 11.21.4 DNA Family Check Products Offered
  • 11.21.5 DNA Family Check Recent Development
• 11.22 Alpha Biolaboratories
  • 11.22.1 Alpha Biolaboratories Corporation Information
  • 11.22.2 Alpha Biolaboratories Description, Business Overview and Total Revenue
  • 11.22.3 Alpha Biolaboratories Sales, Revenue and Gross Margin (2015-2020)
  • 11.22.4 Alpha Biolaboratories Products Offered
  • 11.22.5 Alpha Biolaboratories Recent Development
• 11.23 Test Me DNA
  • 11.23.1 Test Me DNA Corporation Information
  • 11.23.2 Test Me DNA Description, Business Overview and Total Revenue
  • 11.23.3 Test Me DNA Sales, Revenue and Gross Margin (2015-2020)
  • 11.23.4 Test Me DNA Products Offered
  • 11.23.5 Test Me DNA Recent Development
• 11.24 23 Mofang
  • 11.24.1 23 Mofang Corporation Information
  • 11.24.2 23 Mofang Description, Business Overview and Total Revenue
  • 11.24.3 23 Mofang Sales, Revenue and Gross Margin (2015-2020)
  • 11.24.4 23 Mofang Products Offered
  • 11.24.5 23 Mofang Recent Development
• 11.25 Genetic Health
  • 11.25.1 Genetic Health Corporation Information
  • 11.25.2 Genetic Health Description, Business Overview and Total Revenue
  • 11.25.3 Genetic Health Sales, Revenue and Gross Margin (2015-2020)
  • 11.25.4 Genetic Health Products Offered
  • 11.25.5 Genetic Health Recent Development
• 11.26 DNA Services of America
  • 11.26.1 DNA Services of America Corporation Information
  • 11.26.2 DNA Services of America Description, Business Overview and Total Revenue
  • 11.26.3 DNA Services of America Sales, Revenue and Gross Margin (2015-2020)
  • 11.26.4 DNA Services of America Products Offered
  • 11.26.5 DNA Services of America Recent Development
• 11.27 Shuwen Health Sciences
  • 11.27.1 Shuwen Health Sciences Corporation Information
  • 11.27.2 Shuwen Health Sciences Description, Business Overview and Total Revenue
  • 11.27.3 Shuwen Health Sciences Sales, Revenue and Gross Margin (2015-2020)
  • 11.27.4 Shuwen Health Sciences Products Offered
  • 11.27.5 Shuwen Health Sciences Recent Development
• 11.28 Mapmygenome
  • 11.28.1 Mapmygenome Corporation Information
  • 11.28.2 Mapmygenome Description, Business Overview and Total Revenue
  • 11.28.3 Mapmygenome Sales, Revenue and Gross Margin (2015-2020)
  • 11.28.4 Mapmygenome Products Offered
  • 11.28.5 Mapmygenome Recent Development
• 11.29 Full Genomes
  • 11.29.1 Full Genomes Corporation Information
  • 11.29.2 Full Genomes Description, Business Overview and Total Revenue
  • 11.29.3 Full Genomes Sales, Revenue and Gross Margin (2015-2020)
  • 11.29.4 Full Genomes Products Offered
  • 11.29.5 Full Genomes Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

• 12.1 Disease Risk and Health DNA Test Market Estimates and Projections by Region
  • 12.1.1 Global Disease Risk and Health DNA Test Sales Forecast by Regions 2021-2026
  • 12.1.2 Global Disease Risk and Health DNA Test Revenue Forecast by Regions 2021-2026
• 12.2 North America Disease Risk and Health DNA Test Market Size Forecast (2021-2026)
  • 12.2.1 North America: Disease Risk and Health DNA Test Sales Forecast (2021-2026)
  • 12.2.2 North America: Disease Risk and Health DNA Test Revenue Forecast (2021-2026)
  • 12.2.3 North America: Disease Risk and Health DNA Test Market Size Forecast by Country (2021-2026)
• 12.3 Europe Disease Risk and Health DNA Test Market Size Forecast (2021-2026)
  • 12.3.1 Europe: Disease Risk and Health DNA Test Sales Forecast (2021-2026)
  • 12.3.2 Europe: Disease Risk and Health DNA Test Revenue Forecast (2021-2026)
  • 12.3.3 Europe: Disease Risk and Health DNA Test Market Size Forecast by Country (2021-2026)
• 12.4 Asia Pacific Disease Risk and Health DNA Test Market Size Forecast (2021-2026)
  • 12.4.1 Asia Pacific: Disease Risk and Health DNA Test Sales Forecast (2021-2026)
  • 12.4.2 Asia Pacific: Disease Risk and Health DNA Test Revenue Forecast (2021-2026)
  • 12.4.3 Asia Pacific: Disease Risk and Health DNA Test Market Size Forecast by Region (2021-2026)
• 12.5 Latin America Disease Risk and Health DNA Test Market Size Forecast (2021-2026)
  • 12.5.1 Latin America: Disease Risk and Health DNA Test Sales Forecast (2021-2026)
  • 12.5.2 Latin America: Disease Risk and Health DNA Test Revenue Forecast (2021-2026)
  • 12.5.3 Latin America: Disease Risk and Health DNA Test Market Size Forecast by Country (2021-2026)
• 12.6 Middle East and Africa Disease Risk and Health DNA Test Market Size Forecast (2021-2026)
  • 12.6.1 Middle East and Africa: Disease Risk and Health DNA Test Sales Forecast (2021-2026)
  • 12.6.2 Middle East and Africa: Disease Risk and Health DNA Test Revenue Forecast (2021-2026)
  • 12.6.3 Middle East and Africa: Disease Risk and Health DNA Test Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Porter’s Five Forces Analysis
• 13.5 Primary Interviews with Key Disease Risk and Health DNA Test Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Disease Risk and Health DNA Test Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source